Table 2.
Top eight co-cited references related to RNA methylation in DM and its complications.
| No. | Author | Year | Reference | Citation | Centrality |
|---|---|---|---|---|---|
| 1 | Yang Y | 2019 | Glucose is involved in the dynamic regulation of m6A in patients with type 2 diabetes | 16 | 0.02 |
| 2 | Roundtree IA | 2017 | Dynamic RNA modifications in gene expression regulation | 15 | 0 |
| 3 | Huang HL | 2018 | Recognition of RNA N-6- methyladenosine by IGF2BP proteins enhances mRNA stability and translation | 14 | 0.19 |
| 4 | Bhattacharyya OK | 2008 | Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines | 14 | 0 |
| 5 | De Jesus DF | 2019 | m6A mRNA methylation regulates human beta-cell biology in physiological states and in type 2 diabetes | 13 | 0.01 |
| 6 | Xie W | 2019 | METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism | 9 | 0 |
| 7 | Shi HL | 2017 | YTHDF3 facilitates translation and decay of N-6-methyladenosine-modified RNA | 9 | 0 |
| 8 | Lin SB | 2016 | The m6A Methyltransferase METTL3 promotes translation in human cancer cells | 9 | 0 |